± HEALTH Objective To evaluate the accuracy, completeness, clarity, source transparency, and readability of leading AI…+ HEALTH Background Early prediction of in-hospital mortality in critically ill patients can aid clinicians in optimiz…+ HEALTH Hypertension is a major risk factor for cardiovascular diseases, with changes in gut microbiota composition a…+ SCIENCE Fire ants (Solenopsis spp. Westwood) pose a major ecological and economic threat, mainly due to the invasive…± HEALTH Objectives The current study aimed to quantify the diagnostic accuracy of commonly utilized chatbots includin…+ HEALTH Objective Despite elevated risk for epilepsy following traumatic brain injury (TBI), there are limited tools…± HEALTH Timely and accurate diagnosis of ST-elevation myocardial infarction (STEMI) is critical in military operation…+ HEALTH Colorectal cancer (CRC) exhibits substantial metabolic heterogeneity. This study developed a robust prognosti…
TruaceTracing the truth around AIWednesday, August 5, 2026
Subscribe
TRV-2026-0628Version 1 · Certified

Written 2026-08-03 06:07:54 UTC · current record

Reason for this version

Certified into the record

Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-0628
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-08-03T06:07:54.878562Z
status: published
lens: g_space
sector: health
headline: Prediction of coronary atherosclerosis progression in type 2 diabetes mellitus based on AI-derived CCTA parameters and clinical factors: a follow-up study
dek: Objective To develop a predictive model for coronary atherosclerosis progression in patients with type 2 diabetes mellitus (T2DM) based on Artificial intelligence(AI)-derived coronary computed tomography angiography (CCTA) parameters combined with clinical indicators. Methods This retrospective study enrolled 114 patients with T2DM and non-obstructive coronary artery disease (1%-49% stenosis) who underwent CCTA at our hospital between September 2019 and September 2024. After follow-up of 1-5 years, patients were…
gain_title: Researchers developed a nomogram using AI-derived CCTA measures of pericoronary adipose tissue and plaque plus HbA1c to predict progression of non-obstructive coronary lesions in T2DM patients.
problem_title: (none)
trace_subject: (none)
gain_reading: Researchers developed a nomogram using AI-derived CCTA measures of pericoronary adipose tissue and plaque plus HbA1c to predict progression of non-obstructive coronary lesions in T2DM patients.
gain_evidence: LAD-FAI and plaque length and HbA1c are independent predictors for the progression of non-obstructive coronary lesions in T2DM patients.
problem_reading: (none)
problem_evidence: (none)
quick_read: Between 2019 and 2024, researchers retrospectively followed 114 patients with type 2 diabetes and non-obstructive coronary artery disease who had baseline CCTA. Using AI-derived measurements of pericoronary adipose tissue and coronary plaques combined with clinical labs, they built a logistic regression nomogram to distinguish 48 patients who later had infarction, revascularization, or stenosis 265 50% from 66 who did not.

The work matters because non-obstructive lesions in diabetes can still progress to major events, and a noninvasive imaging-based risk tool could guide earlier preventive management. What remains uncertain from the supplied text is external validation, generalizability beyond one center and 114 patients, and whether use of the nomogram changes outcomes or costs in practice.
limitation: 
tag: Evidence-backed gain
key_points: Retrospective study of 114 T2DM patients with 1%-49% stenosis on CCTA between September 2019 and September 2024, followed 1-5 years. | 48 patients progressed defined as acute myocardial infarction, revascularization, or stenosis progression to 265 50% on follow-up CCTA versus 66 controls. | Progression group had significantly higher glycated hemoglobin (HbA1c) and troponin, and lower HDL-C. | Model used stepwise logistic regression combining AI-derived PCAT and plaque parameters with clinical indicators.
rundown: The study enrolled 114 patients with T2DM and non-obstructive disease at a single hospital from September 2019 to September 2024, with 1-5 year follow-up. Progression was defined as acute myocardial infarction, revascularization, or stenosis reaching 265 50% on repeat CCTA.

Clinical and AI-quantified PCAT and plaque features were compared between groups, and stepwise logistic regression identified LAD-FAI, plaque length, and HbA1c as independent predictors incorporated into a nomogram.
sources:
- peer_reviewed | Acta Diabetologica | https://doi.org/10.1007/s00592-026-02761-x | 2026-08-01
prev: 0000000000000000000000000000000000000000000000000000000000000000
sha256
9f9e4c71e1022806e9adda4145f646d379b5318499c24346c43e695bc5a42898
previous
0000000000000000000000000000000000000000000000000000000000000000
Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-0628 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.